Literature DB >> 8645451

Immunoprotection of therapeutic cell transplants by encapsulation.

P J Morris1.   

Abstract

The inflammatory response to an allogeneic or xenogeneic tissue transplant by the recipient is complex and includes both the specific immune response, and the non-specific response resulting from damage during implantation, ischaemic reperfusion injury and partial necrosis of the transplanted tissue. Transplantation of allogeneic or xenogeneic tissue within a biomembrane requires that the biomembrane be biologically inert, and that the mean pore size is adequate to allow the passage of oxygen and nutrition of the enclosed tissues, egress of the desired hormone or growth factor, while protecting the enclosed tissue from both the specific and non-specific responses of the host.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645451     DOI: 10.1016/0167-7799(96)10020-2

Source DB:  PubMed          Journal:  Trends Biotechnol        ISSN: 0167-7799            Impact factor:   19.536


  8 in total

1.  Use of Encapsulated Stem Cells to Overcome the Bottleneck of Cell Availability for Cell Therapy Approaches.

Authors:  D Freimark; P Pino-Grace; S Pohl; C Weber; C Wallrapp; P Geigle; R Pörtner; P Czermak
Journal:  Transfus Med Hemother       Date:  2010-03-08       Impact factor: 3.747

Review 2.  Mesenchymal stem cells engineered for cancer therapy.

Authors:  Khalid Shah
Journal:  Adv Drug Deliv Rev       Date:  2011-06-29       Impact factor: 15.470

3.  Hybrid shell engineering of animal cells for immune protections and regulation of drug delivery: towards the design of "artificial organs".

Authors:  Philippe Dandoy; Christophe F Meunier; Carine Michiels; Bao-Lian Su
Journal:  PLoS One       Date:  2011-06-22       Impact factor: 3.240

Review 4.  Encapsulated cellular implants for recombinant protein delivery and therapeutic modulation of the immune system.

Authors:  Aurélien Lathuilière; Nicolas Mach; Bernard L Schneider
Journal:  Int J Mol Sci       Date:  2015-05-08       Impact factor: 5.923

Review 5.  Blood-brain barrier and foetal-onset hydrocephalus, with a view on potential novel treatments beyond managing CSF flow.

Authors:  M Guerra; J L Blázquez; E M Rodríguez
Journal:  Fluids Barriers CNS       Date:  2017-07-13

6.  A hybrid assembly by encapsulation of human cells within mineralised beads for cell therapy.

Authors:  Philippe Dandoy; Christophe F Meunier; Grégory Leroux; Virginie Voisin; Laetitia Giordano; Nathalie Caron; Carine Michiels; Bao-Lian Su
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

Review 7.  Encapsulated stem cells for cancer therapy.

Authors:  Khalid Shah
Journal:  Biomatter       Date:  2013-01-01

Review 8.  Cell microencapsulation with synthetic polymers.

Authors:  Ronke M Olabisi
Journal:  J Biomed Mater Res A       Date:  2014-08-18       Impact factor: 4.396

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.